Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Capasso, Immacolata ^a   Esposito, Emanuela ^a   De Laurentiis, Michelino ^a   Maurea, Nicola ^a   Cavalcanti, Ernesta ^a   Botti, Gerardo ^a   Petrillo, Antonella ^a   Montella, Maurizio ^a   D'Aiuto, Massimiliano ^a   Coppola, Carmela ^a   Crispo, Anna ^a   Grimaldi, Maria ^a   Frasci, Giuseppe ^a   Fucito, Alfredo ^a   Ciliberto, Gennaro ^a   D'Aiuto, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

BMI; Breast cancer; Insulin resistance; Metabolic syndrome; Molecular subtype; Waist circumference

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROGESTERONE RECEPTOR; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 84908407654     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-105     Document Type: Article

References (29)

1. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO: A prospective study of obesity and cancer risk (Sweden). Canc Causes Contr 2001, 12(1):13-21.
2. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study C: Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ 2007, 335 (7630):1134.
3. National cholesterol education program expert panel on detection E, treatment of high blood cholesterol in A: Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002, 106(25):3143-3421.
4. Vona-Davis L, Rose DP: Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy. Curr Diabetes Rev 2012, 8(2):116-130.
5. Simpson ER, Brown KA: Minireview: obesity and breast cancer: a tale of inflammation and dysregulated metabolism. Mol Endocrinol 2013, 27(5):715-725.
6. Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco M, Cavalcanti E, D'Aiuto M, Fucito A, Frasci G, Maurea N, Esposito G, Pedicini T, Vecchione A, D'Aiuto G, Giordano A: Metabolic syndrome affects breast cancer risk in postmenopausal women: national cancer institute of Naples experience. Canc Biol Ther 2010, 10(12):1240-1243.
7. Hall IJ, Newman B, Millikan RC, Moorman PG: Body size and breast cancer risk in black women and white women: the Carolina breast cancer study. Am J Epidemiol 2000, 151(8):754-764.
8. Khandekar MJ, Cohen P, Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011, 11(12):886-895.
9. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Canc 2009, 16(4):1103-1123.
10. Capasso I, Esposito E, Pentimalli F, Montella M, Crispo A, Maurea N, D'Aiuto M, Fucito A, Grimaldi M, Cavalcanti E, Esposito G, Brillante G, Lodato S, Pedicini T, D'Aiuto G, Ciliberto G, Giordano A: Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: national cancer institute of Naples experience. J Exp Clin Canc Res 2013, 32:14.
11. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998, 351(9113):1393-1396.
12. Kaaks R: Plasma insulin, IGF-I and breast cancer. Gynecol Obstet Fertil 2001, 29(3):185-191.
13. Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA: Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 1997, 3(10):1141-1144.
14. Vitale G, Brugts MP, Ogliari G, Castaldi D, Fatti LM, Varewijck AJ, Lamberts SW, Monti D, Bucci L, Cevenini E, Cavagnini F, Franceschi C, Hofland LJ, Mari D, Janssen J: Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians ' offspring. Aging 2012, 4(9):580-589.
15. Luo Z, Zang M, Guo W: AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 2010, 6(3):457-470.
16. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Canc Res 2010, 12(5):R68.
17. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007, 8(5):R76.
18. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, et al: Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2011, 103(3):250-263.
19. Bowers LW, Cavazos DA, Maximo IX, Brenner AJ, Hursting SD, deGraffenried LA: Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression. Breast Canc Res 2013, 15(4):R59.
20. Mazzarella L, Disalvatore D, Bagnardi V, Rotmensz N, Galbiati D, Caputo S, Curigliano G, Pelicci PG: Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients. Eur J Cancer 2013, 49(17):3588-3597.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
22. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21(12):2191-2192.
23. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 1998, 47(10):1643-1649.
24. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, Huh KB, Kim DJ: Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006, 21(4):695-700.
25. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11(2):155-168.
26. Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ: Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States food and drug administration-approved scoring system. J Clin Oncol Off J Am Soc Clin Oncol 1999, 17(7):1983-1987.
27. Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009, 101(10):736-750.
28. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ, Panel M: Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol 2013, 24(9):2206-2223.
29. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 2006, 295(21):2492-2502.